BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25612120)

  • 1. Severe cutaneous adverse reaction to telaprevir.
    Shuster M; Do D; Nambudiri V
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug rash with eosinophilia and systemic symptoms due to telaprevir.
    Montaudié H; Passeron T; Cardot-Leccia N; Sebbag N; Lacour JP
    Dermatology; 2010; 221(4):303-5. PubMed ID: 20798484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms.
    Cengiz FP; Su O; Emiroglu N; Biyik Ozkaya D; Bahali AG; Onsun N
    G Ital Dermatol Venereol; 2019 Aug; 154(4):488-491. PubMed ID: 31251007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telaprevir-induced DRESS.
    Kesar V; Kesar V; Khaitova V; Motamed D; Schiano T
    J Drugs Dermatol; 2014 Feb; 13(2):199-200. PubMed ID: 24509972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug Rash with Eosinophilia and Systemic Symptoms syndrome induced by telaprevir in a patient with chronic hepatitis C virus infection].
    Martín Domínguez V; Carrascosa de Lome R; Becerro González I; de Argila D; Villar K; García-Buey L
    Gastroenterol Hepatol; 2015 Oct; 38(8):491-3. PubMed ID: 25454599
    [No Abstract]   [Full Text] [Related]  

  • 8. Telaprevir-related dermatitis.
    Roujeau JC; Mockenhaupt M; Tahan SR; Henshaw J; Martin EC; Harding M; van Baelen B; Bengtsson L; Singhal P; Kauffman RS; Stern RS
    JAMA Dermatol; 2013 Feb; 149(2):152-8. PubMed ID: 23560295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case of drug rash eosinophilia and systemic symptoms due to boceprevir.
    Samain A; Duval-Modeste AB; Joly P; Leblanc C; Massy N; Courville P; Goria O; Riachi G
    J Hepatol; 2014 Apr; 60(4):891-3. PubMed ID: 24333861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-acting antiviral-associated dermatitis during chronic hepatitis C virus treatment.
    Biesbroeck LK; Scott JD; Taraska C; Moore E; Falsey RR; Shinohara MM
    Am J Clin Dermatol; 2013 Dec; 14(6):497-502. PubMed ID: 23775427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia].
    Gamba C; Schroeder J; Citterio A; Cazzaniga S; Rivolta AL; Vighi G;
    Recenti Prog Med; 2014 Oct; 105(10):379-84. PubMed ID: 25282350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of drug-induced reactions in DRESS patients.
    Picard D; Vellar M; Janela B; Roussel A; Joly P; Musette P
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):801-4. PubMed ID: 24628777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug reaction with eosinophilia and systemic symptoms].
    Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
    Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognostic factors in severe cutaneous drug reactions.
    Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
    Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe cutaneous drug reactions in children].
    Mockenhaupt M
    Hautarzt; 2017 Oct; 68(10):803-814. PubMed ID: 28932875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of severe cutaneous drug eruptions.
    Bachot N; Roujeau JC
    Am J Clin Dermatol; 2003; 4(8):561-72. PubMed ID: 12862499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.